The Analytical Scientist
  • Explore

    Explore

    • Latest
    • News & Research
    • Trends & Challenges
    • Keynote Interviews
    • Opinion & Personal Narratives
    • Product Profiles
    • App Notes
    • The Product Book

    Featured Topics

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy

    Issues

    • Latest Issue
    • Archive
  • Topics

    Techniques & Tools

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy
    • Microscopy
    • Sensors
    • Data and AI

    • View All Topics

    Applications & Fields

    • Clinical
    • Environmental
    • Food, Beverage & Agriculture
    • Pharma and Biopharma
    • Omics
    • Forensics
  • People & Profiles

    People & Profiles

    • Power List
    • Voices in the Community
    • Sitting Down With
    • Authors & Contributors
  • Business & Education

    Business & Education

    • Innovation
    • Business & Entrepreneurship
    • Career Pathways
  • Events
    • Live Events
    • Webinars
  • Multimedia
    • Video
    • Content Hubs
Subscribe
Subscribe

False

The Analytical Scientist / Issues / 2026 / October / New Tick-Borne Virus Identified in China
Microscopy Genomics & DNA Analysis

New Tick-Borne Virus Identified in China

Molecular and antibody assays identified ALTNV in patients with fever after tick exposure

10/07/2026 2 min read
  • Full Article
  • Summary
  • Takeaways
  • Listen
  • Report
  • Scorecard
  • Quiz
  • Poll
  • Topic Commentary

Share

Clinical Report: New Tick-Borne Virus Identified in China

Overview

Researchers identified Asian longhorned tick nairovirus (ALTNV), a distinct orthonairovirus, in febrile patients in China, including patients who tested negative for Dabie bandavirus (DBV), the cause of severe fever with thrombocytopenia syndrome (SFTS). In a screening cohort of 3,163 patients with fever and recent tick exposure, 10.4% had ALTNV RNA or immunoglobulin M evidence of infection; among those testing negative for DBV, 15.1% had evidence of ALTNV infection. Patients with ALTNV alone recovered without reported lasting complications, while the study could not establish whether ALTNV contributed to greater severity in coinfected patients.

Background

SFTS, caused by DBV, can present with fever, thrombocytopenia, and other laboratory abnormalities. More than 30% of patients given a clinical diagnosis of SFTS test negative for DBV, indicating that other pathogens may produce similar findings. ALTNV was identified through hospital surveillance of febrile patients with tick exposure in regions where tick-borne diseases are common. The virus was also detected in ticks collected across multiple Chinese provinces, including Haemaphysalis longicornis, the Asian longhorned tick.

Data Highlights

MeasureFinding
Patients screened with fever and recent tick exposure3,163
Patients with ALTNV RNA or IgM evidence10.4%
DBV-negative patients with ALTNV evidence15.1%
ALTNV-only patients56; all recovered without reported lasting complications
ALTNV-only clinical findingsFatigue, 84%; gastrointestinal symptoms, 80%; thrombocytopenia, 38%; elevated aminotransferases, 36%
Patients coinfected with ALTNV and DBV38; seven died
Respiratory symptoms in coinfection vs DBV alone61% vs 38%
Kidney impairment in coinfection vs DBV alone84% vs 66%
Ticks tested across 15 provinces47,428; ALTNV RNA detected in 1.29%
ALTNV RNA detection in H. longicornis1.75%

Key Findings

  • RNA sequencing identified ALTNV in patients with suspected SFTS who tested negative for DBV; genomic analysis classified it as a distinct orthonairovirus.
  • Researchers isolated the virus from RNA-positive patient serum in cultured cells and confirmed its identity using immunofluorescence; electron microscopy showed orthonairovirus structural features.
  • Laboratory confirmation used two RT-qPCR assays targeting different genomic regions, followed by additional PCR testing and Sanger sequencing; an ELISA was used to detect ALTNV IgM.
  • Among 56 patients infected only with ALTNV, fatigue and gastrointestinal symptoms were common, and all recovered without reported lasting complications.
  • Among 38 patients coinfected with ALTNV and DBV, respiratory symptoms and kidney impairment were more frequent than in patients with DBV alone; seven coinfected patients died. The study could not determine whether ALTNV contributed to greater severity.
  • ALTNV RNA was detected in 1.29% of 47,428 ticks sampled across 15 provinces, with the highest reported rate in H. longicornis; laboratory experiments showed this tick could transmit the virus to mice.

Conclusion

ALTNV was identified in febrile patients and ticks in China and can produce clinical findings that overlap with SFTS. Its contribution to disease severity in coinfected patients and its broader distribution remain undetermined.

Related Resources & Content

  1. New England Journal of Medicine, 2026 -- A Zoonotic Orthonairovirus from Febrile Patients in China
  2. Open Forum Infectious Diseases, 2025 -- Identification of Tick-borne Encephalitis Virus in Ixodes Ticks Collected in Proximity to Ulaanbaatar, Mongolia
  3. International Journal of Infectious Diseases, 2026 -- Investigation of a Family and Healthcare-Related Outbreak of Severe Fever with Thrombocytopenia Syndrome in Shanghai, China: An Epidemiological Study in a Non-Endemic Region
  4. International Journal of Infectious Diseases, 2026 -- Enhancing data collection on socio-behavioral exposure pathways for emerging tickborne disease through engagement with surviving cases and their household members
  5. ADA News — China’s mosquito offensive: what you need to know about chikungunya virus
  6. A Zoonotic Orthonairovirus from Febrile Patients in China
  7. Viral haemorrhagic fevers: epidemiology, characteristics, diagnosis and management
  8. Diagnosis, management, and prevention of Crimean-Congo haemorrhagic fever: a Delphi-based consensus study in Türkiye
  9. A Zoonotic Orthonairovirus from Febrile Patients in China | New England Journal of Medicine
  10. Diagnosis, management, and prevention of Crimean-Congo haemorrhagic fever: a Delphi-based consensus study in Türkiye - ScienceDirect
  11. 发热伴血小板减少综合征合并细菌/真菌感染诊治与防控专家共识
  12. Frontiers | Research progress on antiviral drugs and vaccines for severe fever with thrombocytopenia syndrome
  13. Field Investigation of Two Urban Cases of Severe Fever with Thrombocytopenia Syndrome — Nanjing City, Jiangsu Province, China, 2025

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Newsletters

Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

Recommended

False

Related Content

The Analytical Scientist Innovation Awards 2024: #3
Microscopy
The Analytical Scientist Innovation Awards 2024: #3

December 6, 2024

4 min read

Bruker’s multiphoton microscopy module, OptoVolt, ranks third in our Innovation Awards. Here, Jimmy Fong, product development lead, walks us through the major moments during development.

Let Me See That Brain
Microscopy
Let Me See That Brain

December 9, 2024

1 min read

TRISCO sets a new standard for 3D RNA imaging, delivering high-resolution and uniform images to offer insights into brain function and anatomy

Loading the Molecular Dice
Microscopy
Loading the Molecular Dice

December 12, 2024

2 min read

How a framework for controlling molecular reactions at the atomic scale has potential implications for nanotechnology, pharmaceutical synthesis, and clean energy research

Found in Translation
Microscopy
Found in Translation

December 16, 2024

1 min read

Cryo-EM addresses a key question in gene expression: how ribosomes initiate translation

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

False

The Analytical Scientist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.